|
Real-time Estimate
Cboe BZX
02:04:10 29/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 7.025 USD | +5.64% |
|
+9.38% | +122.93% |
| 10-25 | Agenus Inc. Reports Early Phase 2 Results From dMMR Colon Cancer Cohort Of NEOASIS Study | CI |
| 10-08 | Agenus Gets Armenia Approval for Botensilimab-Balstilimab Combination | MT |
| Market Cap | 299M 269M 248M 225M 420M 28.51B 425M 2.97B 1.18B 14.92B 1.12B 1.1B 47.37B | P/E 2026 * |
27x | P/E 2027 * | -14x |
|---|---|---|---|---|---|
| Enterprise Value | 299M 269M 248M 225M 420M 28.51B 425M 2.97B 1.18B 14.92B 1.12B 1.1B 47.37B | EV / Sales 2026 * |
2.39x | EV / Sales 2027 * | 2.58x |
| Free-Float |
93.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AGEN | Delayed | |
CBOE
| AGEN | Real-time | |
|
Tradegate
| AJ8 | Real-time | |
|
Boerse Muenchen
| AJ8 | Real-time | |
|
Deutsche Boerse AG
| AJ8 | Delayed |
Last Transcript: Agenus Inc.
| 1 day | +5.64% | ||
| 1 week | +9.38% | ||
| Current month | -29.51% | ||
| 1 month | -25.77% | ||
| 3 months | +6.06% | ||
| 6 months | +79.95% | ||
| Current year | +122.93% |
| 1 week | 6.11 |  | 7.05 |
| 1 month | 6 | | 10.31 |
| Current year | 2.71 | | 10.31 |
| 1 year | 2.71 | | 10.31 |
| 3 years | 1.38 | | 19.69 |
| 5 years | 1.38 | | 93.8 |
| 10 years | 1.38 | | 135.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Garo Armen
CEO | Chief Executive Officer | 73 | 31/03/1994 |
Kamel Djazouli
CTO | Chief Tech/Sci/R&D Officer | - | - |
Craig Winter
CTO | Chief Tech/Sci/R&D Officer | - | 01/11/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Garo Armen
CHM | Chairman | 73 | 04/11/2010 |
Brian Corvese
BRD | Director/Board Member | 68 | 08/03/2007 |
Timothy Wright
BRD | Director/Board Member | 68 | 07/12/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Free | Director | 1,179 | 0.0026% | ||
| 1/10/26 | Free | Director | 4,443 | 0.0098% | ||
| 10/8/26 | Free | Chief Executive Officer | 1,971,500 | 4.4054% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.64% | +9.38% | +73.27% | -55.96% | 299M | |
| +0.65% | -3.56% | +33.53% | +60.50% | 63.48B | |
| +1.76% | +1.27% | +11.82% | +82.12% | 54.55B | |
| -0.94% | +0.99% | +10.45% | +102.18% | 53.59B | |
| +2.59% | +0.19% | +27.06% | +56.45% | 44.75B | |
| +2.32% | -3.17% | +18.11% | +100.54% | 41.62B | |
| +0.21% | -4.06% | +220.41% | +915.72% | 39.91B | |
| +0.64% | -3.85% | +11.71% | +45.57% | 32.47B | |
| +29.06% | +47.63% | +107.12% | +94.27% | 26.7B | |
| +3.72% | -7.45% | +24.25% | -2.99% | 23.36B | |
| Average | +4.54% | -0.02% | +53.77% | +139.84% | 38.07B | |
| Weighted average by Cap. | +3.10% | -0.29% | +47.08% | +160.13% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 125M 112M 104M 94.06M 176M 11.92B 178M 1.24B 495M 6.24B 470M 460M 19.81B | 116M 104M 96.19M 87.12M 163M 11.04B 165M 1.15B 458M 5.78B 435M 426M 18.35B |
| Net income | 39.4M 35.35M 32.68M 29.6M 55.3M 3.75B 55.97M 391M 156M 1.96B 148M 145M 6.23B | -28.55M -25.62M -23.68M -21.45M -40.07M -2.72B -40.56M -283M -113M -1.42B -107M -105M -4.52B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | US$7.000 | +5.26% | 305,637 |
| 27/10/26 | US$6.650 | +7.95% | 839,017 |
| 26/10/26 | US$6.160 | -2.69% | 687,893 |
| 23/10/26 | US$6.330 | -2.76% | 510,514 |
| 22/10/26 | US$6.510 | +1.72% | 553,954 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AGEN Stock
Select your edition
All financial news and data tailored to specific country editions
